Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FM7B4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,995
Award facts
- Contract value 100% obligated
- $12,994.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 16, 2025, with completion targeted for January 8, 2026. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The auto-injector delivery supports the company's broader pharmaceutical supply mission to the Defense Health Agency and other government healthcare organizations.
This delivery order is issued under AmerisourceBergen Drug Corp's $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to make multiple regional awards, positioning AmerisourceBergen among key contractors supporting federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FM7B4?
SPE2DR26FM7B4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM7B4 worth?
The government has obligated $12,995 on SPE2DR26FM7B4.
Is contract SPE2DR26FM7B4 an order under another contract?
Yes. SPE2DR26FM7B4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7B4 competed?
The extent of competition for SPE2DR26FM7B4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award